Immunoglobulin A (IgA), immunoglobulin M (IgM), and immunoglobulin G (IgG) against S and N proteins of SARS-CoV-2 evolve rapidly within 1 to 2 weeks after symptoms onset in the sera of COVID-19 patients [9–12]. This evidence concerns the gene CD79A and COVID-19.